GLIPR1 and chronic myelogenous leukemia, BCR-ABL1 positive: Promoter hypermethylation has also been found to reduce RTVP-1 expression in acute myeloid leukemia patients compared with lymphoblastic leukemia, chronic myeloid leukemia and remission bone marrow (11).